Basics |
Innovus Pharmaceuticals Inc
|
IPO Date: |
March 4, 2021 |
Sector: |
Healthcare |
Industry: |
Medical Care Facilities |
Market Cap: |
$527.9M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.21 | 3.06%
|
Avg Daily Range (30 D): |
$0.10 | 3.01%
|
Avg Daily Range (90 D): |
$0.09 | 2.82%
|
Institutional Daily Volume |
Avg Daily Volume: |
.14M |
Avg Daily Volume (30 D): |
.02M |
Avg Daily Volume (90 D): |
.03M |
Trade Size |
Avg Trade Size (Sh.): |
105 |
Avg Trade Size (Sh.) (30 D): |
67 |
Avg Trade Size (Sh.) (90 D): |
75 |
Institutional Trades |
Total Inst.Trades: |
115 |
Avg Inst. Trade: |
$2.5M |
Avg Inst. Trade (30 D): |
$.67M |
Avg Inst. Trade (90 D): |
$.67M |
Avg Inst. Trade Volume: |
.14M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$4.86M |
Avg Closing Trade (30 D): |
$.67M |
Avg Closing Trade (90 D): |
$.67M |
Avg Closing Volume: |
246.33K |
|
|
Financials |
|
TTM |
Q3 2025 |
Q2 2025 |
Basic EPS
|
$-.24
|
$-.08
|
|
Diluted EPS
|
$-.24
|
$-.08
|
|
Revenue
|
$ 831.68M
|
$ 218.14M
|
$
|
Gross Profit
|
$ 148.93M
|
$ 40.75M
|
$
|
Net Income / Loss
|
$ -32.59M
|
$ -11.13M
|
$
|
Operating Income / Loss
|
$ -32.49M
|
$ -10.16M
|
$
|
Cost of Revenue
|
$ 257.08M
|
$ 69.5M
|
$
|
Net Cash Flow
|
$ 6.36M
|
$
|
$
|
PE Ratio
|
|
|
|
Splits |
Mar 18, 2019:
1:105
|
|
|
|